Exploring the Role of Oral JAK Inhibitors in Atopic Dermatitis - Episode 8
Utilizing Patient Factors to Guide Treatment Selection in Atopic Dermatitis
Experts discuss situations where an oral JAK inhibitor might be prescribed initially over a biologic for moderate to severe atopic dermatitis (AD), noting advantages such as oral administration, quicker onset of action, and convenience, which may make it a preferred option for some patients.
Video content above is prompted by the following:
- What are some circumstances where you would prescribe an oral JAK inhibitor for moderate to severe AD initially over a biologic?
- What advantages might a JAK inhibitor have over a biologic?
